Medical devices, healthcare technology and the business of care
PMA approval · P140013

MINERVA ENDOMETRIAL ABLATION SYSTEM

Axora Medical, Inc. · Decision date Jul 27, 2015

MEDTECHLEDGER EXPLANATIONP140013

What did the FDA approve?

FDA PMA P140013 is an approval for the MINERVA ENDOMETRIAL ABLATION SYSTEM. The database entry states the device category as a thermal ablation endometrial device and the specialty as Obstetrics/Gynecology, but it does not add any technical details beyond the named system and its field label.

The stated scope is ablation of the endometrial lining of the uterus in pre-menopausal women with menorrhagia due to benign causes, for whom childbearing is complete. This is the approval statement for the PMA record itself; the supplied data do not describe a supplement, a later change, or any separate manufacturing notice.

FDA approval order statement

APPROVAL FOR THE MINERVA ENDOMETRIAL ABLATION SYSTEM. THIS DEVICE IS INDICATED FOR ABLATION OF THE ENDOMETRIAL LINING OF THE UTERUS IN PRE-MENOPAUSAL WOMEN WITH MENORRHAGIA (EXCESSIVE BLEEDING) DUE TO BENIGN CAUSES FOR WHOM CHILDBEARING IS COMPLETE.
Regulatory pathway
Original PMA
Clinical specialty
Obstetrics/Gynecology
Decision date
Jul 27, 2015

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140013
Regulatory pathway
Premarket approval application
Product code
MNB
Decision code
APPR
Decision date
Jul 27, 2015
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, thermal ablation, endometrial.

Product code
MNB
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P140013 received

    Application receipt date recorded by FDA.

  2. P140013 · FDA decision

    APPR

  3. P140013/S019 · Related supplement

    MINERVA ENDOMETRIAL ABLATION SYSTEM

Timeline entries are records held by MedtechLedger for P140013. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140013

Product / regulatory recordCompanyPathwayDecision dateSource
Axora Medical, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code MNB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Axora Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1 Independent Dr. Suite 2300, Jacksonville, FL, 32202

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records